| Gene |
[PCNA](/genes/pcna) |
| UniProt ID |
P12004 |
| Molecular Weight |
28.8 kDa |
| Structure |
Homotrimeric ring (PDB: 1AXC) |
| Subcellular Localization |
Nucleus |
| Protein Family |
PCNA family, DNA clamp proteins |
| Disease Relevance |
[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer, DNA Repair Disorders |
Proliferating Cell Nuclear Antigen (PCNA) is a homotrimeric ring-shaped protein that functions as a sliding clamp for DNA polymerases during DNA replication and repair 1. Often called the "molecular toolbelt" of the cell, PCNA serves as a central platform for recruiting proteins involved in DNA metabolism, including DNA polymerases, DNA ligases, and cell cycle regulators 2. First identified as a nuclear antigen present in proliferating cells, PCNA has since been recognized as a critical component of DNA replication and repair machinery across all eukaryotes 3.
Beyond its canonical roles in DNA replication, PCNA has been implicated in various neurodegenerative diseases, particularly those involving DNA repair dysfunction and replicative stress. The protein's interaction with multiple partner proteins and its regulation by post-translational modifications make it a central hub for coordinating DNA metabolism with cell cycle progression and cellular responses to genotoxic stress 4.
PCNA forms a distinctive homotrimeric ring structure:
Ring Architecture:
- Each monomer is approximately 28.8 kDa
- Three monomers assemble into a ring-shaped homotrimer
- The ring encircles double-stranded DNA 5
Monomer Structure:
- Each PCNA monomer contains two topologically closed domains
- An interdomain connecting loop (IDCL) protrudes from the ring
- The IDCL is critical for protein-protein interactions 6
DNA Interaction:
- The central channel specifically interacts with DNA
- The channel diameter accommodates B-form DNA
- This interaction enables the sliding clamp function 7
PCNA utilizes multiple surfaces for protein interactions:
Front Face:
- Primary interaction surface for many partners
- Binding site for DNA polymerases
- Recognizes PIP (PCNA-interacting peptide) motifs 8
Back Face:
- Less commonly used for interactions
- May regulate PCNA function
- Some regulatory proteins bind here 9
Interdomain Connecting Loop (IDCL):
- Critical for partner protein interactions
- Contains conserved binding motifs
- Undergoes conformational changes upon partner binding 10
PCNA is essential for processive DNA replication:
Sliding Clamp Function:
- PCNA encircles DNA and slides along the template
- Tethers DNA polymerases to the DNA template
- Increases processivity from ~100 to >10,000 nucleotides 11
Polymerase Switching:
- PCNA facilitates switching between polymerases
- Enables accessory proteins during Okazaki fragment synthesis
- Coordinates leading and lagging strand synthesis 12
PCNA plays central roles in multiple DNA repair pathways:
Base Excision Repair (BER):
- PCNA recruits DNA glycosylases
- Facilitates polymerase access to damaged bases
- Coordinates gap-filling synthesis 13
Nucleotide Excision Repair (NER):
- PCNA is loaded onto UV-damaged DNA
- Recruits repair endonucleases
- Coordinates dual incision events 14
Mismatch Repair (MMR):
- PCNA interacts with MMR proteins
- Recognizes mismatched base pairs
- Initiates repair synthesis 15
Homologous Recombination (HR):
- PCNA functions in recombination repair
- Regulates RAD51 filament formation
- Coordinates DNA synthesis in HR 16
PCNA integrates DNA metabolism with cell cycle progression:
S Phase Entry:
- PCNA expression peaks in S phase
- Required for DNA replication initiation
- Phosphorylated forms have distinct functions 17
Cell Cycle Checkpoints:
- PCNA interacts with checkpoint proteins
- p53-independent checkpoint activation
- Arrest upon DNA damage 18
PCNA is regulated by phosphorylation:
Serine Phosphorylation:
- Casein kinase 2 (CK2) phosphorylates PCNA
- Affects protein-protein interactions
- Regulates S-phase progression 19
Threonine Phosphorylation:
- Cyclin-dependent kinases (CDKs) phosphorylate PCNA
- Links cell cycle to DNA metabolism
- Required for proper S-phase function 20
PCNA ubiquitination regulates DNA repair:
Mono-ubiquitination:
- Rad6/Rad18 catalyzes PCNA mono-ubiquitination
- Initiates translesion synthesis (TLS)
- Allows bypass of DNA lesions 21
Poly-ubiquitination:
- UBC13/Mms2/Rad5 catalyzes polyubiquitin chain formation
- Directs error-free DNA repair
- Requires prior mono-ubiquitination 22
SUMOylation:
- PCNA can be sumoylated
- Inhibits homologous recombination
- Balances repair pathway choice 23
Pol δ:
- Primary lagging strand polymerase
- Requires PCNA for processive synthesis
- Interacts via PIP box motif 24
Pol ε:
- Primary leading strand polymerase
- Less dependent on PCNA
- Has distinct PCNA interactions 25
Pol η:
- Translesion synthesis polymerase
- Bypasses UV-induced lesions
- Directly interacts with PCNA 26
DNA Ligase I:
- Joins Okazaki fragments
- Interacts with PCNA during lagging strand synthesis
- Essential for DNA replication completion 27
Flap Endonuclease 1 (FEN1):
- Processes flap structures
- Recruited by PCNA
- Essential for DNA repair 28
p21 WAF1/CIP1:
- Cell cycle regulator
- Binds PCNA via C-terminus
- Inhibits PCNA function 29
PCNA dysfunction contributes to AD pathophysiology:
DNA Repair Impairment:
- Reduced PCNA expression in AD brain
- Impaired DNA repair capacity
- Accumulation of DNA damage 30
Cell Cycle Re-entry:
- Aberrant PCNA expression in neurons
- Attempted cell cycle re-entry
- Leads to neuronal death 31
Therapeutic Implications:
- PCNA-enhancing strategies being explored
- DNA repair enhancement as AD treatment
- Targeting cell cycle dysregulation 32
PCNA is implicated in PD pathogenesis:
Mitochondrial DNA Repair:
- PCNA participates in mitochondrial DNA repair
- Mitochondrial dysfunction in PD
- Contributes to dopaminergic neuron loss 33
Oxidative Stress Response:
- PCNA responds to oxidative DNA damage
- Oxidative stress in PD substantia nigra
- PCNA recruitment to damaged sites 34
PCNA mutations cause human disease:
Ataxia-telangiectasia-like Disease:
- PCNA mutations cause neurodegenerative phenotype
- Impaired DNA damage response
- Cerebellar degeneration 35
DNA Repair-Deficient Syndromes:
- Combined immunodeficiency with microcephaly
- Growth retardation
- Neurological deficits 36
PCNA is a cancer therapeutic target:
Inhibitor Development:
- PCNA inhibitors block DNA replication
- Selective toxicity for proliferating cells
- Being developed as anticancer agents 37
Combination Therapy:
- PCNA inhibitors synergize with genotoxic agents
- Enhances tumor cell killing
- Clinical trials ongoing 38
Approaches for neurodegenerative disease:
DNA Repair Enhancement:
- PCNA-activating compounds
- Enhance DNA repair capacity
- Protect neurons from cell death 39
Cell Cycle Inhibition:
- Prevent aberrant neuronal cell cycle re-entry
- CDK inhibitors under investigation
- Protect against neurodegeneration 40
X-ray Crystallography:
- First PCNA structure solved in 1995
- Revealed homotrimeric ring architecture
- Basis for understanding function 41
Cryo-EM:
- Recent advances in cryo-EM
- PCNA complexes with partner proteins
- Dynamic conformational changes 42
DNA Replication Assays:
- In vitro replication systems
- SV40-based replication assays
- Measure PCNA function 43
DNA Repair Assays:
- Host cell reactivation assays
- Comet assays for DNA damage
- Repair pathway-specific assays 44
Co-immunoprecipitation:
- Identify PCNA binding partners
- Validate protein interactions
- Characterize complex formation 45
Peptide Arrays:
- Screen for PCNA-interacting peptides
- Define binding motifs
- Identify novel partners 46
PCNA is highly conserved:
Yeast:
- Saccharomyces cerevisiae PCNA (POL30)
- 85% identity with human PCNA
- Essential for viability 47
Drosophila:
- Drosophila PCNA (mus209)
- Highly similar structure
- Mutations cause developmental defects 48
Mammals:
- Mouse, rat, human PCNA nearly identical
- Functional conservation
- Knockout lethal 49
PCNA belongs to the sliding clamp family:
PCNA vs. Other Clamps:
- Bacterial β-clamp: functional homolog
- Archaeal PCNA: more complex
- Eukaryotic PCNA: most elaborate 50
- How is PCNA loaded specifically to repair sites?
- What determines pathway choice between HR and TLS?
- How does PCNA dysfunction lead to neurodegeneration?
- Can we selectively enhance neuronal DNA repair?
- Single-molecule studies: Real-time observation of PCNA function
- Cell-type specific roles: Understanding PCNA in neurons vs. glia
- Therapeutic modulation: Developing neuroprotective PCNA-targeting drugs 51
PCNA is a central protein in DNA metabolism, functioning as a sliding clamp for DNA polymerases during replication and repair. Its homotrimeric ring structure encircles DNA and provides a platform for recruiting numerous partner proteins involved in DNA synthesis, repair, and cell cycle regulation. PCNA is regulated by multiple post-translational modifications, including phosphorylation, ubiquitination, and sumoylation, which direct its function in different DNA repair pathways. Dysregulation of PCNA contributes to neurodegenerative diseases, particularly those involving DNA repair dysfunction and aberrant cell cycle re-entry. Understanding PCNA's functions and developing therapeutic strategies to modulate its activity represent important goals for treating both cancer and neurodegenerative disorders.
PCNA as a disease biomarker:
Diagnostic Markers:
- PCNA expression in cerebrospinal fluid
- Correlates with disease progression
- Non-invasive monitoring possible 52
Prognostic Value:
- PCNA levels predict disease course
- Therapy response indicators
- Patient stratification markers 53
Targeting PCNA for drug discovery:
Inhibitor Screening:
- High-throughput screening platforms
- Structure-based design approaches
- Lead optimization strategies 54
Clinical Development:
- First-generation inhibitors in trials
- Combination strategies
- Patient selection biomarkers 55
Functional Variants:
- Single nucleotide polymorphisms (SNPs)
- Affect protein expression or function
- Disease susceptibility associations 56
Population Genetics:
- Variant frequencies across populations
- Evolutionary conservation
- Disease association studies 57
Knockout Studies:
- PCNA knockout lethal in mice
- Embryonic lethality
- Essential for cell proliferation 58
Conditional Knockouts:
- Tissue-specific deletion
- Neuron-specific knockouts
- Modeling neurodegeneration 59
Transgenic Models:
- Overexpression models
- Mutant PCNA transgenes
- Disease modeling 60
Protein Purification:
- Recombinant expression systems
- Insect cell expression
- Mammalian cell expression 61
Antibody Development:
- Monoclonal antibodies
- Phospho-specific antibodies
- Cross-reactivity considerations 62
DNA Replication Assays:
- Optimizing polymerase interactions
- Detergent considerations
- ATP requirements 63
Interaction Assays:
- Surface plasmon resonance
- Isothermal titration calorimetry
- Fluorescence polarization 64
PCNA is a central protein in DNA metabolism with critical roles in replication, repair, and cell cycle regulation. Its structure as a homotrimeric sliding clamp, its numerous protein partners, and its regulation by post-translational modifications make it essential for cellular homeostasis. Dysregulation of PCNA contributes to neurodegenerative diseases through impaired DNA repair and aberrant cell cycle re-entry. Targeting PCNA for therapeutic intervention offers promise for both cancer treatment and neuroprotection.